Sodium-glucose cotransporter-2 inhibitors and cardiovascular outcomes: insights from the CVD-REAL study

Marwan Saad^{1

2}

Affiliations

¹ Department of Cardiovascular Disease, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
² Department of Cardiovascular Disease, Ain Shams University, Cairo, Egypt.

Editorial

Marwan Saad. Ann Transl Med. 2018 Feb.

. 2018 Feb;6(3):55.

doi: 10.21037/atm.2017.11.08.

Marwan Saad^{1

2}

¹ Department of Cardiovascular Disease, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
² Department of Cardiovascular Disease, Ain Shams University, Cairo, Egypt.

No abstract available

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs: The CVD-REAL Study (Comparative Effectiveness of Cardiovascular Outcomes in New Users of Sodium-Glucose Cotransporter-2 Inhibitors).
Kosiborod M, Cavender MA, Fu AZ, Wilding JP, Khunti K, Holl RW, Norhammar A, Birkeland KI, Jørgensen ME, Thuresson M, Arya N, Bodegård J, Hammar N, Fenici P; CVD-REAL Investigators and Study Group*. Kosiborod M, et al. Circulation. 2017 Jul 18;136(3):249-259. doi: 10.1161/CIRCULATIONAHA.117.029190. Epub 2017 May 18. Circulation. 2017. PMID: 28522450 Free PMC article. Clinical Trial.

1. Emerging Risk Factors Collaboration , Di Angelantonio E, Kaptoge S, et al. Association of cardiometabolic multimorbidity with mortality. JAMA 2015;314:52-60. 10.1001/jama.2015.7008 - DOI - PMC - PubMed
1. Abdul-Ghani M, Del Prato S, Chilton R, et al. SGLT2 inhibitors and cardiovascular risk: lessons learned from the EMPA-REG OUTCOME study. Diabetes Care 2016;39:717-25. 10.2337/dc16-0041 - DOI - PMC - PubMed
1. Action to Control Cardiovascular Risk in Diabetes Study Group , Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59. 10.1056/NEJMoa0802743 - DOI - PMC - PubMed
1. ADVANCE Collaborative Group , Patel A, MacMahon S, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72. 10.1056/NEJMoa0802987 - DOI - PubMed
1. Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-39. 10.1056/NEJMoa0808431 - DOI - PubMed